Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Sulfonyhydrazine prodrug VNP-40101M advances towards phase II clinical evaluation

Dec. 4, 2002

SU-11248: preclinical and early clinical findings encourage further development

Dec. 4, 2002

Improved survival rate found with 131I-ch81C6 in malignant brain tumors

Dec. 4, 2002

Promising toxicity and antitumor efficacy for temozolomide + vatalanib succinate in glioblastoma

Dec. 4, 2002

Aventis claims CDK2 inhibitors for cancer and chemotherapy-induced neuronal apoptosis

Dec. 4, 2002

Celltech presents novel receptor tyrosine kinase inhibitors for cancer, psoriasis, etc.

Dec. 4, 2002

Phase I data demonstrate promising efficacy and safety for oral Raf kinase inhibitor

Dec. 3, 2002

Radiosensitizing effects of karenitecin in human glioma cells

Dec. 3, 2002

Evidence that trimidox sensitizes malignant glioma cells to ionizing radiation

Dec. 3, 2002

Inhibitors of tubulin polymerization prepared and tested at Aventis

Dec. 3, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...